These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia. Jones RN; Jacobs MR; Sader HS Int J Antimicrob Agents; 2010 Sep; 36(3):197-204. PubMed ID: 20558045 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection. Yanagihara K; Izumikawa K; Higa F; Tateyama M; Tokimatsu I; Hiramatsu K; Fujita J; Kadota J; Kohno S Intern Med; 2009; 48(7):527-35. PubMed ID: 19336954 [TBL] [Abstract][Full Text] [Related]
8. Drug treatment of pneumococcal pneumonia in the elderly. Neralla S; Meyer KC Drugs Aging; 2004; 21(13):851-64. PubMed ID: 15493950 [TBL] [Abstract][Full Text] [Related]
9. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased? Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678 [TBL] [Abstract][Full Text] [Related]
10. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae. Yayan J Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917 [TBL] [Abstract][Full Text] [Related]
11. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study. Carugati M; Aliberti S; Sotgiu G; Blasi F; Gori A; Menendez R; Encheva M; Gallego M; Leuschner P; Ruiz-Buitrago S; Battaglia S; Fantini R; Pascual-Guardia S; Marin-Corral J; Restrepo MI; Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1513-1525. PubMed ID: 32242314 [TBL] [Abstract][Full Text] [Related]
12. Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel. Regev-Yochay G; Chowers M; Chazan B; Gonzalez E; Gray S; Zhang Z; Pride M Hum Vaccin Immunother; 2018; 14(10):2527-2532. PubMed ID: 30188760 [TBL] [Abstract][Full Text] [Related]
14. Prospective, population-based surveillance of the burden of Streptococcus pneumoniae in community-acquired pneumonia in older adults, Chrzanów County, Poland, 2010 to 2012. Harat R; Alexander R; Gray S; Gutterman EM; Pluta J; Pride M; Shite S; Fijolek J; Kozub J Pneumonol Alergol Pol; 2016; 84(2):95-103. PubMed ID: 27238167 [TBL] [Abstract][Full Text] [Related]
15. Clinical and microbiological characteristics of community-acquired pneumonia associated with Streptococcus pneumoniae in adult patients in Mexico. Echaniz-Aviles G; Garza-González E; Román-Mancha AL; Morfín-Otero R; Rodríguez-Noriega E; Ayala-Gaytán JJ; Guajardo-Lara CE; Soto-Nogueron A; Carnalla-Barajas MN; Camacho-Ortiz A Rev Argent Microbiol; 2019; 51(3):234-240. PubMed ID: 30635204 [TBL] [Abstract][Full Text] [Related]
16. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae. Jones RN; Sader HS; Stilwell MG; Fritsche TR Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan. Takeuchi N; Naito S; Ohkusu M; Abe K; Shizuno K; Takahashi Y; Omata Y; Nakazawa T; Takeshita K; Hishiki H; Hoshino T; Sato Y; Ishiwada N Epidemiol Infect; 2020 Apr; 148():e91. PubMed ID: 32299523 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology Characteristics of Zhao W; Pan F; Wang B; Wang C; Sun Y; Zhang T; Shi Y; Zhang H Front Cell Infect Microbiol; 2019; 9():258. PubMed ID: 31380301 [No Abstract] [Full Text] [Related]
19. Epidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting: results from the 1999-2000 respiratory surveillance program. Gotfried MH Am J Med; 2001 Dec; 111 Suppl 9A():25S-29S; discussion 36S-38S. PubMed ID: 11755440 [TBL] [Abstract][Full Text] [Related]
20. Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern. File TM Am J Med; 2004 Aug; 117 Suppl 3A(3):39S-50S. PubMed ID: 15360096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]